A share price of Co-Diagnostics Inc [CODX] is currently trading at $0.26, down -11.28%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CODX shares have gain 6.19% over the last week, with a monthly amount drifted -27.21%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Co-Diagnostics Inc [NASDAQ: CODX] stock has seen the most recent analyst activity on August 12, 2022, when Sidoti downgraded its rating to a Neutral but kept the price target unchanged to $5 for it. Previously, Sidoti started tracking the stock with Buy rating on December 29, 2021, and set its price target to $14. On March 29, 2021, downgrade downgraded it’s rating to Hold. Maxim Group upgraded its rating to a Buy. H.C. Wainwright reiterated its recommendation of a Buy and raised its price target to $35 on May 18, 2020. H.C. Wainwright reiterated a Buy rating for this stock on March 09, 2020, and upped its price target to $20. In a note dated March 03, 2020, Maxim Group downgraded an Hold rating on this stock.
Co-Diagnostics Inc experienced fluctuations in its stock price throughout the past year between $0.23 and $2.23. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Co-Diagnostics Inc [NASDAQ: CODX] shares were valued at $0.26 at the most recent close of the market. An investor can expect a potential return of 2207.69% based on the average CODX price forecast.
Analyzing the CODX fundamentals
Trailing Twelve Months sales for Co-Diagnostics Inc [NASDAQ:CODX] were 0.57M which represents -80.11% decline. Gross Profit Margin for this corporation currently stands at -0.12% with Operating Profit Margin at -40.79%, Pretax Profit Margin comes in at -35.75%, and Net Profit Margin reading is -35.79%. To continue investigating profitability, this company’s Return on Assets is posted at -0.65, Equity is -0.6 and Total Capital is -0.82. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2253 points at the first support level, and at 0.1952 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3103, and for the 2nd resistance point, it is at 0.3652.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Co-Diagnostics Inc [NASDAQ:CODX] is 4.43. In addition, the Quick Ratio stands at 4.23 and the Cash Ratio stands at 0.35. Considering the valuation of this stock, the price to sales ratio is 15.11, the price to book ratio is 0.18.
